Opioid Use Post-Discharge After Ambulatory Distal Arm Surgery
Discharge Opioid Prescription for Ambulatory Hand and Forearm Surgery: A Randomized Controlled Trial
1 other identifier
interventional
292
1 country
1
Brief Summary
The aim of this study is to determine if a standardized evidence-based opioid prescription following elective hand and forearm surgery at Toronto Western Hospital (TWH) will decrease the number of unused opioid pills consumed by patients while still maintaining adequate pain control as compared to usual treatment. Currently, no standardized prescription exists at our institution.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 4, 2019
CompletedFirst Submitted
Initial submission to the registry
May 23, 2019
CompletedFirst Posted
Study publicly available on registry
August 5, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
January 16, 2026
January 1, 2026
7.8 years
May 23, 2019
January 14, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Impact of Standardized prescription on quality of analgesia after hand and forearm surgery
Twelve weeks after intervention
Secondary Outcomes (13)
Incidence of adverse effects of opioid medications experienced by patients
One week, Six weeks and Twelve weeks after intervention
Correlation of opioid consumption to pain scores
One week, Six weeks and Twelve weeks after intervention
Correlation of opioid consumption to functional limitations post-operatively as measured by the Disabilities of Arm Shoulder and Hand (DASH) score
Six weeks and Twelve weeks after intervention compared to pre-intervention
Incidence of disposal practices of prescribed opioids by patients
One week, Six weeks and Twelve weeks after intervention
Patient satisfaction with pain management after discharge (as measured on a 0 to 10 scale, 0 being completely dissatisfied, and 10 being completely satisfied)
One week, Six weeks and Twelve weeks after intervention
- +8 more secondary outcomes
Other Outcomes (7)
Correlation of patient anxiety on pain numerical rating scores (0-10)
Twelve weeks after intervention compared to pre-intervention
Correlation of patient anxiety on opioid consumption
Twelve weeks after intervention compared to pre-intervention
Correlation of patient depression on pain numerical rating scores (0-10)
Twelve weeks after intervention compared to pre-intervention
- +4 more other outcomes
Study Arms (2)
Standardized Discharge Prescription
ACTIVE COMPARATORBased on a previous study examining mean number of opioid pills used by patients undergoing elective, unilateral hand and forearm surgery
Usual Discharge Prescription
NO INTERVENTIONRoutine standard of care involves prescription for opioids at the discretion of the surgical team
Interventions
Oxycodone 5mg PO q4-6h PRN If patient has allergy or other contraindications Hydromorphone 1mg PO q4-6h PRN/ Tylenol #3 1-2 tablets PO q4h PRN The number of tablets prescribed will depend on the extent of surgical trauma * 0-5 pills for simple surgeries such as a trigger finger release * 10 pills for carpal tunnel or Dupuytren's contracture releases * 15 pills for a ganglion cyst excision or simple tendon transfer * 20 pills for more complex procedures such as distal forearm ORIF or a wrist fusion.
Eligibility Criteria
You may qualify if:
- \. Patients presenting to TWH for elective ambulatory hand and forearm surgery
You may not qualify if:
- Chronic opioid treatment, defined as more than 6 tablets of Oxycodone 5 mg per day (or equivalent)
- Cognitive impairment or any other condition causing inability to use 'as required' medication for pain control
- Language barrier preventing completion of patient diary
- Patient refusal
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Toronto Western Hospital
Toronto, Ontario, M5T2S8, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
Anuj Bhatia, MD FRCPC
UHN
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 23, 2019
First Posted
August 5, 2019
Study Start
March 4, 2019
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
January 16, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share